Literature DB >> 7749955

Pharmacy applications of the transtheoretical model in smoking cessation.

K S Hudmon1, B A Berger.   

Abstract

The transtheoretical model for intentional behavior change is described, and pharmacists' use of the model in smoking-cessation interventions is discussed. This model combines elements of theories used in psychotherapy and behavior modification. In the model are five stages (precontemplation, contemplation, preparation, action, and maintenance) that describe when behavior change occurs. To be most effective, a health care provider's interventions should match the patient's stage of change. The model also includes 10 cognitive and behavioral processes that describe how change occurs while a person is moving among the stages. The processes (social liberation, dramatic relief, helping relationships, consciousness-raising, environmental reevaluation, reinforcement management, self-reevaluation, stimulus control, counterconditioning, and self-liberation) define change in terms of the coping strategies used. Before intervening, the pharmacist needs to ask questions about the patient's behavior that will identify the stage. If smokers in the precontemplation stage are receiving medications for chronic diseases, pharmacists can make them aware of the negative effects of smoking on their specific conditions. People in the contemplation stage are open to education about smoking and health, and those in the preparation stage are ready to set goals and choose methods for cessation. Smokers in the action stage are attempting to quit. Pharmacists can offer support, reinforcement, and guidance to people in the action and maintenance stages. Pharmacists can use the transtheoretical model to categorize patients by their stage of change and then devise and deliver appropriate and individualized interventions.

Entities:  

Mesh:

Year:  1995        PMID: 7749955     DOI: 10.1093/ajhp/52.3.282

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  7 in total

1.  Smoking cessation counseling in Qatar: community pharmacists' attitudes, role perceptions and practices.

Authors:  Maguy Saffouh El Hajj; Reem Raad Al Nakeeb; Raja'a Ali Al-Qudah
Journal:  Int J Clin Pharm       Date:  2012-06-26

2.  Engaging students in wellness and disease prevention services.

Authors:  Audra S Anderson; Jean-Venable R Goode
Journal:  Am J Pharm Educ       Date:  2006-04-15       Impact factor: 2.047

3.  The Process of Cessation Among Current Tobacco Smokers: A Cross-Sectional Data Analysis From 21 Countries, Global Adult Tobacco Survey, 2009-2013.

Authors:  Lazarous Mbulo; Krishna M Palipudi; Glenda Nelson-Blutcher; Komanduri S Murty; Samira Asma
Journal:  Prev Chronic Dis       Date:  2015-09-17       Impact factor: 2.830

4.  Effect of a pharmacist managed smoking cessation clinic on quit rates.

Authors:  Ann M Philbrick; Erin N Newkirk; Karen B Farris; Deanna L McDanel; Kathleen E Horner
Journal:  Pharm Pract (Granada)       Date:  2009-03-15

5.  Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial.

Authors:  Maguy Saffouh El Hajj; Nadir Kheir; Ahmad Mohd Al Mulla; Daoud Al-Badriyeh; Ahmad Al Kaddour; Ziyad R Mahfoud; Mohammad Salehi; Nadia Fanous
Journal:  Trials       Date:  2015-02-26       Impact factor: 2.279

6.  Effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: a randomized controlled trial.

Authors:  Maguy Saffouh El Hajj; Nadir Kheir; Ahmad Mohd Al Mulla; Rula Shami; Nadia Fanous; Ziyad R Mahfoud
Journal:  BMC Public Health       Date:  2017-02-20       Impact factor: 3.295

7.  A pharmacist health coaching trial evaluating behavioural changes in participants with poorly controlled hypertension.

Authors:  Harjit K Singh; Gerard A Kennedy; Ieva Stupans
Journal:  BMC Fam Pract       Date:  2021-02-14       Impact factor: 2.497

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.